InvestorsHub Logo
Followers 10
Posts 1104
Boards Moderated 0
Alias Born 12/07/2012

Re: None

Monday, 01/23/2017 7:19:30 PM

Monday, January 23, 2017 7:19:30 PM

Post# of 38634
Here's a question... I think it was mentioned several times that IPCI couldn't go ahead and manufacture rexista on its own because they would need a US manufacturing site due to import restrictions if I recall?

But are they not the sole manufacture and provider for the drugs in the Mallinckrodt deal?

"Additionally, and as part of that agreement, Intellipharmaceutics remains the sole manufacturer and distributor of the licensed products and will be compensated on a cost-plus basis, with Mallinckrodt agreeing that Intellipharmaceutics will be its sole provider of all licensed products marketed in the U.S."

So if that's the case are they all not being manufactured here in Toronto and sold in the US? Are they a different schedule and that's why the import restrictions?